Korean J Gastrointest Endosc.
2010 Nov;41(5):290-293.
Portal and Mesenteric Venous Thrombosis Complicating Endoscopic Injection Sclerotherapy
- Affiliations
-
- 1Department of Internal Medicine, Seoul Medical Center, Seoul, Korea. kbr207@dreamwiz.com
- 2Department of Pathology, Seoul Medical Center, Seoul, Korea.
Abstract
- Endoscopic injection sclerotherapy is an effective and relatively safe modality for controlling bleeding esophageal varices. Injection of sclerosant causes acute mural thrombosis with a necroinflammatory response and subsequent sclerosis in the venous system of the distal esophagus. A few cases of mesenteric venous thrombosis with small bowel infarction after sclerotherapy have been reported, and most of which were fatal. The association between mesenteric venous thrombosis and sclerotherapy has been strongly suggested, but this still remains unproved. We report here on a case of mesenteric venous thrombosis with small bowel infarction that developed after endoscopic injection sclerotherapy.